Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)
Recruitment status was: Not yet recruiting
Sixty two subjects will take part in this study. The study is unic arm. The subjects used the product once and will be evaluated in the regression of pimples in the times 0,4,6,8 and 24 hours after application.
A follow-up visit will be made 24 hours after initiation of treatment.
|Treatment of Acne Vulgaris Grade II in a Short Period of Time.||Drug: Benzoyl peroxide and sulfur||Phase 4|
|Study Design:||Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
|Official Title:||Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)|
- Clinical study to evaluate the efficacy of topical medications containing benzoyl peroxide and sulfur in the regression in the short time (24 hours) of moderate acne vulgaris grade II (pimples). [ Time Frame: 24 hours ]Clinical evolution of the target lesions for each experimental time regarding the parameters of reddening, size and general appearance of the lesion.
|Study Start Date:||January 2011|
|Estimated Study Completion Date:||March 2011|
|Estimated Primary Completion Date:||March 2011 (Final data collection date for primary outcome measure)|
Experimental: Benzoyl Peroxide and Sulfur
Topical Medications containing benzoyl peroxide and sulfur
Drug: Benzoyl peroxide and sulfur
topical cream, 5% benzoyl peroxide and 2% sulfur Frequency once to day Duration 24 hours
Please refer to this study by its ClinicalTrials.gov identifier: NCT01260571
|Contact: Sergio Schalka, Doctor's||(11) firstname.lastname@example.org|
|Medcin Instituto da Pele||Not yet recruiting|
|Osasco, São Paulo, Brazil, 06023-000|
|Contact: Sergio Schalka, Doctor's (11) 36816362 email@example.com|
|Principal Investigator: Sergio Schalka, Doctor's|